Hepatitis C virus genotypes among HCV-chronic liver disease patients in Egypt: a leading trial

J Egypt Public Health Assoc. 1994;69(5-6):327-34.

Abstract

In this trial, we have checked 50 anti-HCV positive, HCV-RNA PCR positive chronic liver disease cases, 44 males, 6 females with a mean age of 51 years. HCV-RNA extraction and genotyping was carried out at the Department of Medical Microbiology, University of Edinburgh, U.K. results showed that 47 (94%) of patients were of genotype 4 and 3 (6%) were of genotype 1. Liver biopsies were performed in 22 only out of the 50 patients studied. The 3 genotype 1 patients were biopsied, 2 had cirrhotic profile and one had CAH. Of 47 genotype 4 patients, 19 were biopsied, 3 were CPH, 2 had CLH, 9 had CAH, 4 had cirrhosis and one patient had HCC.

Conclusion: It appears that Egypt hosts predominantly HCV genotype 4 and less commonly genotype 1. This finding might have important implications concerning the epidemiological aspects, pathogenesis and response to antiviral therapy.

MeSH terms

  • Chronic Disease
  • Egypt
  • Female
  • Genotype*
  • Hepacivirus / genetics*
  • Hepatitis C / pathology
  • Hepatitis C / virology*
  • Humans
  • Liver Cirrhosis / pathology
  • Liver Cirrhosis / virology
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Risk Assessment
  • Risk Factors
  • Seroepidemiologic Studies